Management of Intrahepatic Cholestasis of Pregnancy with Normal LFTs

Diagnostic Approach

The American College of Obstetricians and Gynecologists recommends measuring both serum bile acids AND liver transaminases when IHCP is suspected, as this is the recommended diagnostic workup (GRADE 1B) 1
Normal LFTs do not exclude IHCP—pruritus can precede the rise in serum bile acid levels by several weeks, according to the American College of Obstetricians and Gynecologists 3
The Society for Maternal-Fetal Medicine advises to repeat bile acid and transaminase measurements if pruritus persists without another explanation, as the biochemical abnormalities may develop later in the disease course 3
The American College of Obstetricians and Gynecologists warns against empiric ursodeoxycholic acid (UDCA) treatment before obtaining laboratory confirmation, as starting UDCA at the time of testing may prevent detection of elevated bile acids or transaminases, making definitive diagnosis impossible 3
The diagnosis of IHCP requires laboratory confirmation of elevated bile acids—clinical symptoms alone are insufficient to justify preterm delivery, as stated by the American College of Obstetricians and Gynecologists 1, 2

The American College of Obstetricians and Gynecologists suggests considering empiric UDCA for severe pruritus only after initial testing is complete and while awaiting repeat results, understanding this may complicate subsequent diagnosis 3
UDCA is the first-line agent for maternal symptom relief (GRADE 1A) and can be used for symptomatic treatment, according to the American College of Obstetricians and Gynecologists 1, 4

The Society for Maternal-Fetal Medicine recommends against initiating antenatal fetal surveillance in patients with pruritus but persistently normal bile acids, as the evidence does not support increased fetal risk in this population 1
Antenatal fetal surveillance should only begin once IHCP is confirmed with elevated bile acids, at a gestational age when delivery would be performed in response to abnormal testing (GRADE 2C), as advised by the Society for Maternal-Fetal Medicine 1, 3

The American College of Obstetricians and Gynecologists strongly recommends against preterm delivery at <37 weeks in patients with clinical suspicion of IHCP but no laboratory confirmation of elevated bile acids (GRADE 1B) 1, 2, 5
This recommendation prioritizes avoiding iatrogenic prematurity-related morbidity when the diagnosis remains uncertain, as stated by the American College of Obstetricians and Gynecologists 2

The Society for Maternal-Fetal Medicine advises serial bile acid and transaminase measurements should continue if pruritus persists, as biochemical abnormalities may emerge weeks after symptom onset 3
The frequency of repeat testing should be guided by symptom severity and clinical suspicion, typically every 1-2 weeks until symptoms resolve or diagnosis is confirmed, according to the Society for Maternal-Fetal Medicine 3
The American College of Obstetricians and Gynecologists recommends reevaluating liver function tests after delivery in patients with persistent pruritus or other hepatobiliary symptoms (right upper quadrant pain, jaundice) 2, 5
The American College of Obstetricians and Gynecologists suggests referring to a liver specialist if serologic abnormalities persist postpartum, as this suggests an underlying hepatobiliary condition rather than IHCP 2, 5

The Society for Maternal-Fetal Medicine warns against the temptation to diagnose IHCP based solely on pruritus—this leads to unnecessary preterm deliveries with associated neonatal morbidity 1, 2
The American College of Obstetricians and Gynecologists advises against assuming normal initial labs rule out IHCP permanently—the biochemical signature may develop later, requiring vigilance and repeat testing 3
The Society for Maternal-Fetal Medicine recommends resisting pressure for early delivery without laboratory confirmation—the SMFM explicitly recommends against this practice (GRADE 1B), as the risks of prematurity outweigh uncertain benefits 1, 2